• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

该国作为欧盟(EU)耐药结核病(DR-TB)高负担国家之一,其抗击结核病的历史经验与实践。

The historical experience and practice of fight against tuberculosis in country which is one of the high drug resistant-tuberculosis (DR-TB) burden countries in European Union (EU).

作者信息

Korablioviene J, Mauricas M, Caplinskas S, Zagrebneviene G, Korabliov P

机构信息

State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.

Centre for Communicable Diseases and AIDS, Vilnius, Lithuania.

出版信息

J Prev Med Hyg. 2018 Dec 15;59(4):E328-E335. doi: 10.15167/2421-4248/jpmh2018.59.4.926. eCollection 2018 Dec.

DOI:10.15167/2421-4248/jpmh2018.59.4.926
PMID:30656237
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6319128/
Abstract

Despite considerable efforts and quite early initiated anti-tuberculosis (TB) actions, Lithuania still remains one of the European Union (EU) countries with the highest tuberculosis rates, especially multidrug-resistant (MDR) TB. According to the European Centre for Disease Prevention and Control, in 2016, 58 994 cases of TB were reported in 30 EU/European Economic Area (EEA) countries. MDR TB was reported for 3.7% of 36 071 cases with drug susceptibility testing results and continues to be highest in the three Baltic countries - Estonia, Latvia and Lithuania. In this article we present the Lithuanian anti-TB action history review and comparison with other countries in this area of action. Literature review was performed by using documents available in the Martynas Mazvydas Library's resource, articles of foreign authors and archival materials. According to archaeological studies, tuberculosis was common in Europe including Lithuania in the Middle Ages. Tuberculosis reporting started in Lithuania in 1926. The first tuberculosis sanatorium in Lithuania was opened in 1891. Patients were treated with sun bathing procedures, fresh air and sunlight. Later the treatment included pneumothorax, toracocaustic, toracoplastic, treatment with gold products and other procedures. Lithuania introduced directly observed treatment, short course therapy (DOTS) in 1999, and since 2007 it has been working in accordance with the requirements of this strategy.

摘要

尽管付出了巨大努力且很早就启动了抗结核行动,但立陶宛仍是欧盟国家中结核病发病率最高的国家之一,尤其是耐多药结核病。根据欧洲疾病预防控制中心的数据,2016年,30个欧盟/欧洲经济区国家报告了58994例结核病病例。在36071例有药敏试验结果的病例中,耐多药结核病报告率为3.7%,在波罗的海三国——爱沙尼亚、拉脱维亚和立陶宛中仍然最高。在本文中,我们介绍立陶宛抗结核行动的历史回顾,并与该行动领域的其他国家进行比较。通过使用马尔蒂纳斯·马兹维达斯图书馆资源中的文件、外国作者的文章和档案材料进行文献综述。根据考古研究,结核病在中世纪的欧洲包括立陶宛都很常见。立陶宛于1926年开始报告结核病。立陶宛的第一家结核病疗养院于1891年开业。患者接受日光浴治疗、呼吸新鲜空气和晒太阳。后来的治疗方法包括气胸、烧灼胸廓、胸廓成形术、用金制品治疗等。立陶宛于1999年引入直接观察治疗短程疗法(DOTS),自2007年以来一直按照该战略的要求开展工作。

相似文献

1
The historical experience and practice of fight against tuberculosis in country which is one of the high drug resistant-tuberculosis (DR-TB) burden countries in European Union (EU).该国作为欧盟(EU)耐药结核病(DR-TB)高负担国家之一,其抗击结核病的历史经验与实践。
J Prev Med Hyg. 2018 Dec 15;59(4):E328-E335. doi: 10.15167/2421-4248/jpmh2018.59.4.926. eCollection 2018 Dec.
2
Migration-related tuberculosis: epidemiology and characteristics of tuberculosis cases originating outside the European Union and European Economic Area, 2007 to 2013.移民相关结核病:2007 至 2013 年起源于欧盟和欧洲经济区以外的结核病病例的流行病学和特征。
Euro Surveill. 2016;21(12). doi: 10.2807/1560-7917.ES.2016.21.12.30164.
3
Drug-resistant tuberculosis in the European Union: opportunities and challenges for control.欧盟的耐药结核病:控制的机遇与挑战。
Tuberculosis (Edinb). 2010 May;90(3):182-7. doi: 10.1016/j.tube.2010.03.008. Epub 2010 Apr 10.
4
In the European Union, TB patients from former Soviet countries have a high risk of multidrug resistance.在欧盟,来自前苏联国家的结核病患者有很高的多重耐药风险。
Int J Tuberc Lung Dis. 2006 Sep;10(9):954-8.
5
Tuberculosis in Poland in 2020.2020年波兰的结核病情况
Przegl Epidemiol. 2022;76(4):528-546. doi: 10.32394/pe.76.48.
6
Tuberculosis in Poland in 2021.2021 年波兰的结核病。
Przegl Epidemiol. 2024 May 20;77(4):449-465. doi: 10.32394/pe.77.37. Epub 2024 Apr 9.
7
Tuberculosis in Poland in 2018.2018 年波兰的结核病。
Przegl Epidemiol. 2020;74(2):239-257. doi: 10.32394/pe.74.19.
8
Multidrug- and extensively drug-resistant tuberculosis: a persistent problem in the European Union European Union and European Economic Area.耐多药和广泛耐药结核病:欧盟及欧洲经济区的一个持续存在的问题。
Euro Surveill. 2010 Mar 18;15(11):19519.
9
Tuberculosis treatment outcome in the European Union and European Economic Area: an analysis of surveillance data from 2002-2011.欧洲联盟和欧洲经济区的结核病治疗结果:2002-2011 年监测数据的分析。
Euro Surveill. 2015;20(49). doi: 10.2807/1560-7917.ES.2015.20.49.30087.
10
The effect of migration within the European Union/European Economic Area on the distribution of tuberculosis, 2007 to 2013.欧盟/欧洲经济区内部移民对结核病分布的影响,2007 年至 2013 年。
Euro Surveill. 2016;21(12). doi: 10.2807/1560-7917.ES.2016.21.12.30171.

引用本文的文献

1
On the relationship between BCG coverage and national COVID-19 outcome: could 'heterologous' herd immunity explain why some countries are better off?关于卡介苗覆盖率与国家 COVID-19 结局的关系:“异源”群体免疫能否解释为何有些国家的情况较好?
J Intern Med. 2020 Dec;288(6):682-688. doi: 10.1111/joim.13198.

本文引用的文献

1
The history of tuberculosis: from the first historical records to the isolation of Koch's bacillus.结核病的历史:从最早的历史记录到科赫氏杆菌的分离
J Prev Med Hyg. 2017 Mar;58(1):E9-E12.
2
Multidrug-resistant tuberculosis in Lithuania - Still a long way ahead.
Medicina (Kaunas). 2016;52(2):69-78. doi: 10.1016/j.medici.2016.02.002. Epub 2016 Mar 3.
3
Treatment of Tuberculosis. A Historical Perspective.结核病的治疗:历史视角
Ann Am Thorac Soc. 2015 Dec;12(12):1749-59. doi: 10.1513/AnnalsATS.201509-632PS.
4
Evidence of probable tuberculosis in Lithuanian mummies.立陶宛木乃伊中可能存在结核病的证据。
Homo. 2015 Oct;66(5):420-31. doi: 10.1016/j.jchb.2015.01.004. Epub 2015 May 14.
5
Tuberculosis, drug resistance, and the history of modern medicine.结核病、耐药性与现代医学史
N Engl J Med. 2012 Sep 6;367(10):931-6. doi: 10.1056/NEJMra1205429.
6
A concurrent comparison of home and sanatorium treatment of pulmonary tuberculosis in South India.印度南部肺结核家庭治疗与疗养院治疗的同期对比。
Bull World Health Organ. 1959;21(1):51-144.
7
Eliminating human tuberculosis in the twenty-first century.在21世纪消除人类结核病。
J R Soc Interface. 2008 Jun 6;5(23):653-62. doi: 10.1098/rsif.2007.1138.
8
Robert Koch and the pathogenesis of tuberculosis.
Int J Tuberc Lung Dis. 2005 Nov;9(11):1181-2.
9
Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis.结核分枝杆菌祖细胞的古老起源与基因镶嵌性
PLoS Pathog. 2005 Sep;1(1):e5. doi: 10.1371/journal.ppat.0010005. Epub 2005 Aug 19.
10
Leon Charles Albert Calmette and BCG vaccine.莱昂·夏尔·阿尔贝·卡尔梅特与卡介苗
Int J Tuberc Lung Dis. 2005 Sep;9(9):944-5.